Literature DB >> 28944949

The research progress of mesenchymal stem cells in the treatment of Traumatic brain injury.

Gang Li1, Yue Yang, Hua-Jiang Dong, Ling Lin.   

Abstract

Traumatic brain injury (TBI) is the leading cause of mortality and morbidity in children and adults throughout the world. It is urgent to ameliorate TBI damage and reduce the disability and case-fatality rate. Stem cell therapy is another medical revolution after drug and surgical medication. Mesenchymal stem cells (MSCs) are a class of cells with significant self-renewal and multi-lineage differentiation properties and be favorable for the treatment of various diseases and injuries, it could be envisioned that MSCs transplantation may be a promising treatment for TBI. Currently, stem cell therapy has shown promising effects in the treatment of many diseases. In this article, we will review the characteristics of MSCs, MSCs for neuronal function restoration, the properties of immune-modulatory of MSCs, and the anti-apoptotic effects of MSCs, the angiogenesis effect of MSCs,and the safety issues in MSCs therapy in TBI.

Entities:  

Year:  2017        PMID: 28944949     DOI: 10.5137/1019-5149.JTN.20829-17.1

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  4 in total

Review 1.  Mesenchymal stem cells in neurodegenerative diseases: Opinion review on ethical dilemmas.

Authors:  Matteo Scopetti; Alessandro Santurro; Vittorio Gatto; Raffaele La Russa; Federico Manetti; Stefano D'Errico; Paola Frati; Vittorio Fineschi
Journal:  World J Stem Cells       Date:  2020-03-26       Impact factor: 5.326

2.  Umbilical cord mesenchymal stem cell (UC-MSC) transplantations for cerebral palsy.

Authors:  Huajiang Dong; Gang Li; Chongzhi Shang; Huijuan Yin; Yuechen Luo; Huipeng Meng; Xiaohong Li; Yali Wang; Ling Lin; Mingliang Zhao
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

Review 3.  Can Mesenchymal Stem Cells Act Multipotential in Traumatic Brain Injury?

Authors:  Fatemeh Dehghanian; Zahra Soltani; Mohammad Khaksari
Journal:  J Mol Neurosci       Date:  2020-01-02       Impact factor: 3.444

4.  Interleukin-1 in cerebrospinal fluid for evaluating the neurological outcome in traumatic brain injury.

Authors:  Yingming Yue; Chongzhi Shang; Huajiang Dong; Kun Meng
Journal:  Biosci Rep       Date:  2019-04-12       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.